BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31214917)

  • 1. The "milky way" galaxy of HIV-related central nervous system immune reaction syndromes.
    Trunfio M; Manini C; Trentalange A; Boghi A; Audagnotto S; Imperiale D; Taraglio S; Bonora S; Di Perri G; Calcagno A
    J Neurovirol; 2019 Dec; 25(6):887-892. PubMed ID: 31214917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy.
    Metz I; Radue EW; Oterino A; Kümpfel T; Wiendl H; Schippling S; Kuhle J; Sahraian MA; Gray F; Jakl V; Häusler D; Brück W
    Acta Neuropathol; 2012 Feb; 123(2):235-45. PubMed ID: 22057786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging changes following natalizumab discontinuation in multiple sclerosis patients with progressive multifocal leukoencephalopathy.
    Hodel J; Bapst B; Outteryck O; Verclytte S; Deramecourt V; Benadjaoud MA; Pruvo JP; Vermersch P; Leclerc X
    Mult Scler; 2018 Dec; 24(14):1902-1908. PubMed ID: 29343163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Not a Disease of the Past: A Case Series of Progressive Multifocal Leukoencephalopathy in the Established Antiretroviral Era.
    Summers NA; Kelley CF; Armstrong W; Marconi VC; Nguyen ML
    AIDS Res Hum Retroviruses; 2019 Jun; 35(6):544-552. PubMed ID: 30834775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy.
    Wattjes MP; Richert ND; Killestein J; de Vos M; Sanchez E; Snaebjornsson P; Cadavid D; Barkhof F
    Mult Scler; 2013 Dec; 19(14):1826-40. PubMed ID: 24192217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy?
    Scarpazza C; Prosperini L; Mancinelli CR; De Rossi N; Lugaresi A; Capobianco M; Moiola L; Naldi P; Imberti L; Gerevini S; Capra R
    J Neurol Sci; 2017 Jul; 378():233-237. PubMed ID: 28566170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with intravenous immunoglobulin in a patient with multiple sclerosis treated with fingolimod after discontinuation of natalizumab.
    Calic Z; Cappelen-Smith C; Hodgkinson SJ; McDougall A; Cuganesan R; Brew BJ
    J Clin Neurosci; 2015 Mar; 22(3):598-600. PubMed ID: 25523125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune-reconstitution Inflammatory Syndrome in Multiple Sclerosis Patients Treated With Natalizumab: A Series of 4 Cases.
    N'gbo N'gbo Ikazabo R; Mostosi C; Quivron B; Delberghe X; El Hafsi K; Lysandropoulos AP
    Clin Ther; 2016 Mar; 38(3):670-5. PubMed ID: 26856928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and prognosis of immune reconstitution inflammatory syndrome in HIV-associated progressive multifocal leucoencephalopathy.
    Sainz-de-la-Maza S; Casado JL; Pérez-Elías MJ; Moreno A; Quereda C; Moreno S; Corral I
    Eur J Neurol; 2016 May; 23(5):919-25. PubMed ID: 26914970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe Progressive Multifocal Leukoencephalopathy (PML) and Spontaneous Immune Reconstitution Inflammatory Syndrome (IRIS) in an Immunocompetent Patient.
    Krey L; Raab P; Sherzay R; Berding G; Stoll M; Stangel M; Wegner F
    Front Immunol; 2019; 10():1188. PubMed ID: 31191548
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune reconstitution inflammatory syndrome in a patient with progressive multifocal leukoencephalopathy.
    Shahani L; Shah M; Tavakoli-Tabasi S
    BMJ Case Rep; 2015 Jun; 2015():. PubMed ID: 26063110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ evidence of JC virus control by CD8+ T cells in PML-IRIS during HIV infection.
    Martin-Blondel G; Bauer J; Cuvinciuc V; Uro-Coste E; Debard A; Massip P; Delisle MB; Lassmann H; Marchou B; Mars LT; Liblau RS
    Neurology; 2013 Sep; 81(11):964-70. PubMed ID: 23935178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probable progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with immunosuppressant dose reduction following lung transplantation: a case report and literature review.
    Ishii K; Yamamoto F; Homma S; Okada Y; Nakamichi K; Saijo M; Tamaoka A
    BMC Neurol; 2019 Oct; 19(1):263. PubMed ID: 31672142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinically silent PML and prolonged immune reconstitution inflammatory syndrome in a patient with multiple sclerosis treated with natalizumab.
    Blinkenberg M; Sellebjerg F; Leffers AM; Madsen CG; Sørensen PS
    Mult Scler; 2013 Aug; 19(9):1226-9. PubMed ID: 23508652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PML-IRIS in an HIV-2-infected patient presenting as Bell's palsy.
    Sierra Morales F; Illingworth C; Lin K; Rivera Agosto I; Powell C; Sloane JA; Koralnik IJ
    J Neurovirol; 2017 Oct; 23(5):789-792. PubMed ID: 28831749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS.
    Wattjes MP; Wijburg MT; Vennegoor A; Witte BI; de Vos M; Richert ND; Uitdehaag BM; Barkhof F; Killestein J;
    J Neurol Neurosurg Psychiatry; 2016 Aug; 87(8):879-84. PubMed ID: 26369555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory natalizumab-associated PML: baseline characteristics, lesion evolution and relation with PML-IRIS.
    Wattjes MP; Wijburg MT; van Eijk J; Frequin S; Uitdehaag BMJ; Barkhof F; Warnke C; Killestein J;
    J Neurol Neurosurg Psychiatry; 2018 May; 89(5):535-541. PubMed ID: 29142146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The spectrum of progressive multifocal leukoencephalopathy: a practical approach.
    Bartsch T; Rempe T; Leypoldt F; Riedel C; Jansen O; Berg D; Deuschl G
    Eur J Neurol; 2019 Apr; 26(4):566-e41. PubMed ID: 30629326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial recovery after severe immune reconstitution inflammatory syndrome in a multiple sclerosis patient with progressive multifocal leukoencephalopathy.
    Calvi A; De Riz M; Pietroboni AM; Ghezzi L; Maltese V; Arighi A; Fumagalli GG; Jacini F; Donelli C; Comi G; Galimberti D; Scarpini E
    Immunotherapy; 2014; 6(1):23-8. PubMed ID: 24341880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune reconstitution inflammatory syndrome and the central nervous system.
    Johnson T; Nath A
    Curr Opin Neurol; 2011 Jun; 24(3):284-90. PubMed ID: 21499099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.